domingo, 28 de mayo de 2023
Safety and immunogenicity of heterologous boosting with orally aerosolised or intramuscular Ad5-nCoV vaccine and homologous boosting with inactivated vaccines (BBIBP-CorV or CoronaVac) in children and adolescents: a randomised, open-label, parallel-controlled, non-inferiority, single-centre study - The Lancet Respiratory Medicine
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario